Grifols Deutschland GmbH secures contract for Pharmaceutical products - drug discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient blood coagulation factor VIII (human) (Fanhdi(r))

Germany, Sept. 29 -- Germany based Grifols Deutschland GmbH has secured contract from AOK Baden-Wurttemberg for Pharmaceutical products - drug discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient blood coagulation factor VIII (human) (Fanhdi(r)). The value of the contract is worth 216000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....